KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Nu Skin Enterprises (NUS) over the last 17 years, with Q3 2025 value amounting to $1.4 million.

  • Nu Skin Enterprises' Deferred Taxes fell 7437.39% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.0 million, marking a year-over-year increase of 25568.4%. This contributed to the annual value of $55.5 million for FY2024, which is 20667.22% up from last year.
  • Nu Skin Enterprises' Deferred Taxes amounted to $1.4 million in Q3 2025, which was down 7437.39% from $7.4 million recorded in Q2 2025.
  • Nu Skin Enterprises' 5-year Deferred Taxes high stood at $54.1 million for Q4 2022, and its period low was -$3.4 million during Q1 2021.
  • Over the past 5 years, Nu Skin Enterprises' median Deferred Taxes value was $356000.0 (recorded in 2021), while the average stood at $6.7 million.
  • In the last 5 years, Nu Skin Enterprises' Deferred Taxes surged by 283969.62% in 2022 and then crashed by 197222.22% in 2024.
  • Nu Skin Enterprises' Deferred Taxes (Quarter) stood at -$2.0 million in 2021, then skyrocketed by 2839.7% to $54.1 million in 2022, then crashed by 84.99% to $8.1 million in 2023, then skyrocketed by 489.24% to $47.9 million in 2024, then plummeted by 97.16% to $1.4 million in 2025.
  • Its Deferred Taxes was $1.4 million in Q3 2025, compared to $7.4 million in Q2 2025 and -$631000.0 in Q1 2025.